Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Prevalence, patterns, and correlates of HIV disclosure among TB-HIV patients initiating antiretroviral therapy in Lesotho

Dados Bibliográficos

ID19440697
AutoresEleanor Hayes-Larson (0000-0001-8299-2389, Columbia University, autor correspondente), Yael Hirsch-Moverman, Yael Hirsch‐Moverman (0000-0003-0096-1306, Columbia University), Suzue Saito (0000-0001-9725-5736, Columbia University), Koen Frederix (Columbia University), Blanche Pitt (Columbia University), Bridget Llang Maama (Ministry of Health), Andrea A Howard (0000-0003-3248-1307, Columbia University)
Ano2017
Volume29
Fascículo8
Páginas978-984
Data de publicação2017-08-03
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoAIDS Care (JOURNAL)
Identificadores do periódicoISSN: 0954-0121 • E-ISSN: 1360-0451
EditoraInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540121.2017.1280124
PMID28100068
OpenAlexW2579439163
IdiomaEN
Citações recebidas2
Referências citadas33

Disclosure of HIV-positive status has important implications for patient outcomes and preventing HIV transmission, but has been understudied in TB-HIV patients. We assessed disclosure patterns and correlates of non-disclosure among adult TB-HIV patients initiating ART enrolled in the START Study, a mixed-methods cluster-randomized trial conducted in Lesotho, which evaluated a combination intervention package (CIP) versus standard of care. Interviewer-administered questionnaire data were analyzed to describe patterns of disclosure. Patient-related factors were assessed for association with non-disclosure to anyone other than a health-care provider and primary partners using generalized linear mixed models. Among 371 participants, 95% had disclosed their HIV diagnosis to someone other than a health-care provider, most commonly a spouse/primary partner (76%). Age, TB knowledge, not planning to disclose TB status, greater perceived TB stigma, and CIP were associated with non-disclosure in unadjusted models (p < .1). In adjusted models, all point estimates were similar and greater TB knowledge (adjusted odds ratio [aOR] 0.59, 95% confidence interval [CI] 0.39-0.90) and CIP (aOR 0.20, 95% CI 0.05-0.79) remained statistically significant. Among 220 participants with a primary partner, 76% had disclosed to that partner. Significant correlates of partner non-disclosure (p < .1) in unadjusted analyses included being female, married/cohabitating, electricity at home, not knowing if partner was HIV-positive, and TB knowledge. Adjusted point estimates were largely similar, and being married/cohabitating (aOR 0.03, 95% CI 0.01-0.12), having electricity at home (aOR 0.38, 95% CI 0.17-0.85) and greater TB knowledge (aOR 0.76, 95% CI 0.59-0.98) remained significant. In conclusion, although nearly all participants reported disclosing their HIV status to someone other than a health-care provider at ART initiation, nearly a quarter of participants with a primary partner had not disclosed to their partner. Additional efforts to support HIV disclosure (e.g., counseling) may be needed for TB-HIV patients, particularly for women and those unaware of their partners' status

Confidence interval · Family medicine · Odds ratio · Spouse · Demography · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Pneumocystis jirovecii pneumonia detection and treatment · Internal Medicine

  • Prevalence and correlates of non-disclosure of maternal HIV status to male partners

    Open Access•John Kinuthia, Benson Singa et al.•BMC Public Health•2018

  • Concerns about starting antiretroviral treatment among pregnant women in Lesotho

    Open Access•Relebohile Nthati Katiso Morojele•Global Public Health•2021

  • Validity/Reliability of PHQ-9 and PHQ-2 Depression Scales Among Adults Living with HIV/Aids in Western Kenya

    Open Access•Patrick O Monahan, Enbal Shacham et al.•Journal of General Internal…•2009

  • The PHQ-9

    Kurt Kroenke, Robert L Spitzer et al.•Journal of General Internal…•2001

  • Development of reliable and valid short forms of the marlowe-crowne social desirability scale

    Open Access•William M Reynolds•Journal of Clinical Psychology•1982

  • The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho

    Open Access•Andrea A Howard, Yael Hirsch-Moverman et al.•Global Health Action•2016

  • Disclosure of HIV serostatus among pregnant and postpartum women in sub-Saharan Africa

    Melanie Tam, Anouk Amzel et al.•AIDS Care•2015

  • Social constraints to TB/HIV healthcare

    Amrita Daftary, Nesri Padayatchi•AIDS Care•2012

  • Serostatus disclosure to sexual partners among people living with HIV

    Sarahmona Przybyla, Sarahmona M Przybyla et al.•AIDS Care•2013

  • Gender differences in HIV disclosure, stigma, and perceptions of health

    Cindy Geary, Cindy Waszak Geary et al.•AIDS Care•2014

  • HIV serostatus disclosure in the treatment cascade

    Joachim Ostermann, Brian W Pence et al.•AIDS Care•2015

  • HIV-positive status disclosure among men and women receiving antiretroviral treatment in eastern Ethiopia

    Ayalu A Reda, Sibhatu Biadgilign et al.•AIDS Care•2013

  • Barriers and outcomes

    Muatale Chileshe, Virginia Bond et al.•AIDS Care•2010

  • HIV testing and disclosure

    Amrita Daftary, Nesri Padayatchi et al.•AIDS Care•2007

  • HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe

    Rena C Patel, Rena Patel et al.•AIDS Care•2012

  • HIV status disclosure to families for social support in South Africa (Nimh Project Accept/HPTN 043)

    Suzanne Maman, Heidi Van Rooyen et al.•AIDS Care•2014

  • Disclosure of HIV status

    Hirut Gebrekristos, Mark N Lurie et al.•African Journal of AIDS Research•2009

  • Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment

    Open Access•Mekdes K Gebremariam, Gunnar A Bjune et al.•BMC Public Health•2010

  • The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence

    Open Access•Michael J Stirratt, Robert H Remien et al.•AIDS and Behavior•2006

  • HIV-Positive Status Disclosure in Patients in Care in Rural South Africa

    Open Access•Quarraisha Abdool Karim, Rachael Dellar et al.•AIDS and Behavior•2015

  • Disclosure of HIV Status to Sex Partners Among HIV-Infected Men and Women in Cape Town, South Africa

    Open Access•Lung Vu, Katherine Andrinopoulos et al.•AIDS and Behavior•2010

  • Men usually say that HIV testing is for women’

    Abby L Dicarlo, Abby DiCarlo et al.•Culture Health & Sexuality•2014

  • Facilitating HIV Disclosure Across Diverse Settings

    Carla Makhlouf Obermeyer, Parijat Baijal et al.•American Journal of Public Health•2011

  • Development of the Alcohol Use Disorders Identification Test (Audit)

    Open Access•Jennifer B Saunders, John B Saunders et al.•Addiction•1993

  • Disclosure of HIV Status

    Open Access•Minrie Greeff, Rene Phetlhu et al.•Qualitative Health Research•2008

  • HIV and tuberculosis

    Open Access•Amrita Daftary•Social Science & Medicine•2012

Obras citantes distintas2
Citações por ano0,25
Intervalo de citações2018 - 2021 (4)
Velocidade de citaçãohistorical
Altamente citadoNão
Tipos de citaçãoNeutras: 2
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae